Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 2/20 | 0.89 |
| ▸ | NPC1 | O15118 | 5/20 | 0.81 |
| ▸ | RAB9A | P51151 | 4/20 | 0.81 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.74 |
| ▸ | MAPT | P10636 | 4/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.74 |
| ▸ | LMNA | P02545 | 1/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.72 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.72 |
| ▸ | MEN1 | O00255 | 1/20 | 0.72 |
| ▸ | TP53 | P04637 | 3/20 | 0.68 |
| ▸ | F2 | P00734 | 2/20 | 0.67 |
| ▸ | HPGD | P15428 | 3/20 | 0.64 |
| ▸ | XBP1 | P17861 | 1/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.62 |
| ▸ | C1R | P00736 | 4/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | PLG | P00747 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29456973 | 0.98 | ELANE (0.93) | ELANENPC1RAB9ARXFP1ALDH1A1 | |
| SCHEMBL125184 | 0.98 | ELANE (0.93) | ELANENPC1RAB9ARXFP1ALDH1A1 | |
| SCHEMBL12212888 | 0.96 | ELANE (0.89) | ELANENPC1RAB9ARXFP1ALDH1A1 | |
| SCHEMBL273036 | 0.95 | ELANE (0.93) | ELANENPC1RAB9ARXFP1ALDH1A1 | |
| SCHEMBL29382161 | 0.94 | ELANE (1.00) | ELANENPC1RAB9ARXFP1ALDH1A1 | |
| SCHEMBL272702 | 0.94 | ELANE (1.00) | ELANENPC1RAB9ARXFP1ALDH1A1 | |
| SCHEMBL914482 | 0.90 | NPC1 (1.00) | ELANENPC1RAB9ARXFP1ALDH1A1 | |
| SCHEMBL913962 | 0.90 | ELANE (0.78) | ELANENPC1RAB9ARXFP1ALDH1A1 | |
| SCHEMBL10325841 | 0.90 | NPC1 (1.00) | ELANENPC1RAB9ARXFP1ALDH1A1 | |
| SCHEMBL30084714 | 0.90 | ELANE (0.78) | ELANENPC1RAB9ARXFP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1438352-B1 | LOW COLOR, LOW SODIUM BENZOXAZINONE UV ABSORBERS AND PROCESS FOR MAKING SAME | CYTEC TECH CORP (US) | 2010-05-26 | — | — | EP | disclosed |
| US-6774232-B2 | FOR USE IN HIGH TRANSPARENCY APPLICATIONS; TO PREVENT DEGRADATION CAUSED BY SUNLIGHT AND OTHER SOURCES OF ULTRAVIOLET (UV) RADIATION OF POLYMERIC MATERIALS | CYTEC TECHNOLOGY CORP. | 2004-08-10 | — | — | US | disclosed |
| EP-1438352-A1 | LOW COLOR, LOW SODIUM BENZOXAZINONE UV ABSORBERS AND PROCESS FOR MAKING SAME | Cytec Technology Corp. (US) | 2004-07-21 | — | — | EP | disclosed |
| US-20030096889-A1 | Low color, low sodium benzoxazinone UV absorbers and process for making same | CYTEC TECHNOLOGY CORP. | 2003-05-22 | — | — | US | disclosed |
| WO-2003035735-A1 | LOW COLOR, LOW SODIUM BENZOXAZINONE UV ABSORBERS AND PROCESS FOR MAKING SAME | CYTEC TECHNOLOGY CORP. (US) | 2003-05-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030096889-A1 | Low color, low sodium benzoxazinone UV absorbers and process for making same | XDH, SI, CA4 | ELANE 2200/4885NPC1 1663/4885RAB9A 2948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.